Consistent with previous studies our results indicate that low-grade invasive cancers are more likely to have the luminal A phenotype, whereas high-grade invasive carcinomas are more likely to be HER2-type and basal-like [6]. This evidence concerns the gene ERBB2 and invasive carcinoma.